Urine-Derived Stem Cells Show Promise for Reversing Aging Through Telomerase Activity
Scientists have identified a promising new approach to combat aging using stem cells derived from urine. These urine-derived stem cells (USCs) contain populations with high telomerase activity and long telomeres, which could address telomere shortening - a key hallmark of biological aging. Unlike other stem cell sources that require invasive procedures, USCs can be collected non-invasively through routine urination. They show robust growth potential, can differentiate into various cell types, and have lower cancer risks compared to other stem cell therapies. Preclinical studies demonstrate their effectiveness in treating age-related disorders, positioning them as an accessible platform for regenerative medicine to combat age-related decline.